Tag Archives: nasal spray vaccine

University of Southampton trial finds promising results for next-generation whooping cough vaccine aimed at preventing colonisation

Posted on 3, December 2025 by EuropaWire PR Editors

(IN BRIEF) A new University of Southampton–led human challenge trial has shown that BPZE1, a nasal spray vaccine for whooping cough, can prevent the bacteria from colonising the nose and throat — a first for any whooping cough vaccine. Conducted … Read the full press release →

Posted in Business, Education, Environment, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged Ashley Dalton, BPZE1, clinical trial, controlled infection model, Diane Gbesemete, human challenge trial, ILiAD Biotechnologies, Marian Knight, nasal spray vaccine, NIHR, NIHR Southampton BRC, NIHR Southampton CRF, PERISCOPE consortium, pertussis, public health, respiratory infections, Robert Read, The Lancet Microbe, UKHSA, University Hospital Southampton, University of Oxford, University of Southampton, University of Southampton research demonstrates strong protection from BPZE1 nasal vaccine against whooping cough spread, vaccine, whooping cough